NIH UPDATE!! Effective immediately, Just-in-Time requests for information require
completion of a Foreign Involvement Section.
This requires the PI to verify the following:
1. collaborator’s name (IF NOT PROVIDED)
2. name and address of the foreign site; (IF NOT PROVIDED IN SF424)
3. estimated total costs of the foreign component/site (if/any) for each year;
4. brief narrative that includes description of the work that will be performed at each foreign site.
5. the involvement of human subjects or animals;
7. extensive foreign travel by grantee project staff for the purpose of data collection, surveying,
sampling, and similar activities;
8. any activity that may have an impact on U.S. foreign policy through involvement in the affairs of
environment of a foreign country;
9. collaboration with investigators at foreign site anticipated to result in co-authorship;
10. use of facilities or instrumentation be used at foreign site;
11. eceipt of financial support or resources from a foreign entity.
There are additional requirements for NIH-funded institutions regarding foreign influence and partners.
We will provide more information as it becomes available.
Federal Websites that will satisfy the Revised Common Rule’s requirement to post
clinical trial consent forms (45 CFR 46.116(h)) - The U.S. Department of Health and Human
Services (HHS) and 16 other federal departments and agencies are announcing where clinical trial
consent forms can be posted, as will be required by the revised Common Rule. No obligations to
post such consent forms apply before January 21, 2019.
The revised Common Rule requires that for any clinical trial conducted or supported by a Common
Rule department or agency, one consent form be posted on a publicly available federal website
within a specific time frame. The consent form must have been used in enrolling participants in
order to satisfy this new provision. You can read more information about the revised Common Rule
on the OHRP website (https://www.hhs.gov/ohrp/education-and-outreach/revised-common-rule/index.html).
At this time, two publicly available federal websites that will satisfy the consent form posting requirement,
as required by the revised Common Rule, have been identified: ClinicalTrials.gov and a docket folder on
Regulations.gov (Docket ID: HHS-OPHS-2018-0021). HHS and other Common Rule departments and
agencies are developing instructions and other materials providing more information to the regulated
community about this posting requirement.
Additional federal websites that would satisfy the revised Common Rule’s clinical trial consent form
posting requirement might be identified in the future.
The National Science Foundation (NSF) is committed to ensuring a fair, competitive, and
transparent merit review process. The reviews submitted by external peer reviewers are an important
part of the decision-making process and a crucial source of feedback to Principal Investigators. NSF
has developed a short reviewer orientation video that provides helpful tips for writing high quality reviews.
NSF encourages all reviewers to watch the orientation video, “The Art and Science of Reviewing
Proposals,” which can be accessed in FastLane through the Panelist Travel and Reimbursement page
and the Proposal Review, Ad Hoc Reviewers page. You can also view the video directly at
There is a link at the end of the video to additional resources, a list of helpful hints, and a short feedback
survey. NSF values your feedback and will use the results of the survey improve future reviewer
Harold Hamm Diabetes Center (HHDC) Research Symposium CALL FOR ABSTRACTS
The abstract submission deadline for the HHDC 2018 Research Symposium is Friday, October 5th
Abstracts must be received by 5 p.m. HHDC 2018 Research Symposium will be held on Friday,
November 16, 2018 at the Samis Education Center in Children’s Hospital in Oklahoma City.
The Symposium will consist of selected oral presentations, a poster session, and Symposia talks by
Silvia Corvera, MD, Professor, University of Massachusetts Medical School, Timothy McGraw PhD,
Professor, Cornell Weill College of Medicine and Morris White, PhD, Professor, Harvard University.
For abstract submission guidelines and to RSVP for this free event, please go to:
http://www.haroldhamm.org/Research/Symposium.aspx Please contact Katie-Hoefling@ouhsc.edu
with any questions for this event.
NOW ACCEPTING APPLICATIONS – Funding to complete the Master of Science
degree in Clinical and Translational Sciences
Now seeking applications for the NIMHD-funded research training and career development program.
The goal of the program is to facilitate the education of participants from diverse backgrounds under-
represented in biomedical research to pursue clinical research or population health research on
diseases that disproportionately impact minority and rural populations in Oklahoma.
The program provides two years of partial salary and research support to complete the Master of
Science degree in Clinical and Translational Sciences (MS in CTS) that is administered through the
OUHSC Graduate College. To be eligible, applicants must hold a clinical doctoral degree or PhD, be
from a group underrepresented in biomedical research (racial and ethnic groups that have been
shown by the National Science Foundation to be underrepresented in biomedical research or individuals
with disabilities), be within seven years of their first faculty appointment, AND plan to pursue a research
career focused on minority health or health disparities research. The 2-year program covers 50%
protected time (salary+fringe), tuition and fees for the MS in CTS degree program, travel to professional
meetings, and modest research funds. Applications are due 10/15/18.
Program and eligibility information is attached. Application materials can be found at:
For additional information, please contact Julie Stoner, PhD (firstname.lastname@example.org).
Prism Software Offered Through Library - Graduate students and Post-docs have been emailed
information for access to a free license for Prism software. Funding for these licenses was provided by
the Provost. With this bulk purchase the Library is again offering Prism licenses to other campus users
at the greatly discounted cost of $45/license.
Licenses expire every year, information about the software, licensing and purchase can be found at
http://library.ouhsc.edu/Prism. If you have questions after reading the information on the web site,
please direct them to email@example.com.
BIOMEDICAL WASTE DISPOSAL
The OUHSC contracted biomedical waste vendor (Stericycle) has expressed a concern regarding the
presence of liquid formalin or other preservatives being improperly disposed of in biomedical waste
containers: Please see attached document for additional information.
https://research.ouhsc.edu/Portals/1329/Assets/Documents/Medical Waste Alert Notice.docx?ver=2018-08-27-073052-173
Diabetes Research: Pilot Project Funding Available – Mentoring Diabetes Research in
Oklahoma CoBRE – Proposal Deadline is September 14, 2018. See attached document for
https://research.ouhsc.edu/Portals/1329/Assets/Documents/Pilot Projects in Diabetes COBRE flyer 2018.pdf?ver=2018-08-27-072837-087
END2CANCER: Emerging Nanotechnology and Drug Delivery Applications for Cancer
Dates: December 6-7, 2018
Location: Samis Education Center
Registration and Call for Abstracts: http://end2cancer.com/
Summary: The END2CANCER conference will start the morning of December 6th, 2018 and conclude
in the afternoon of December 7th, 2018. The conference will bridge laboratory research conducted in
the areas of nanotechnology and drug delivery to clinical application for the detection, diagnosis, imaging
and treatment of cancer. The conference will host keynote, plenary and invited lectures by eminent
scientists who will discuss new and emerging concepts, technologies and challenges in translating
nanomedicine from bench-to-bedside.
Topics to be discussed in the planned thematic sessions include barriers in drug delivery, discovery
and applications, biological and non-biological systems as carriers and therapeutics, molecular imaging,
biomimetics, immune-oncology, toxicology and clinical trials.
The multi-disciplinary two-day conference will bring together physicians, basic scientists, engineers,
physicists, chemists, post-doctoral fellows, high-school and college students, patient advocates, business
professionals, educators and technology transfer specialists. Students and fellows will have an opportunity
to present their work as a poster presentation and compete for awards.
The Oklahoma Clinical and Translational Science Institute (OCTSI) and Oklahoma Shared Clinical
and Translational Resources (OSCTR) is soliciting applications for its Clinical and Translational
Research Pilot (CTRP) Grants Program. The purpose of the program is to provide funding for
collaborative and/or multi-disciplinary clinical and translational pilot projects between investigators of
the OSCTR member institutions.
The program seeks to support proposals designed to generate preliminary data that will result in
improved health and/or healthcare for citizens of Oklahoma and other IDeA states and enhance the
competitiveness of the investigators for future extramural funding. The program also seeks to fund
innovative concepts, approaches, and methodologies that bring fresh new ideas to solving the health
issues of those living in Oklahoma and collaborating IDeA states. Projects that focus on the medically
underserved and on health concerns prevalent within Oklahoma and our OSCTR partners will be a
priority. Only projects which meet the NIH definition of clinical and/or translational research will be
accepted. Proposals are due September 21, 2018. More information can be found at
The Oklahoma Center for Respiratory and Infectious Diseases (OCRID) invites applications for
FY2019 Pilot Project Grants through the NIH CoBRE, with the Center for Veterinary Health Sciences
(CVHS), Oklahoma State University (OSU) and the participation of other OSU colleges, the University
of Oklahoma (OU) Health Science Center (HSC) and Norman, and the Oklahoma Medical Research
Foundation (OMRF). Application Deadline is September 14, 2018.
See attached for more complete information.
Oklahoma Center for Adult Stem Cell Research (OCASCR)
Grants are accepted for research, equipment, travel/education and other areas.
Grant proposal deadline is September 6, 2018 for grants starting January 1, 2019.
For additional information go to:
i2E Entrpreneurial Summit
This annual entrepreneurial event will give you tips, tricks and strategies for entrepreneurs.
Hear from local successful entrepreneurs as they share their personal stories on how they
got started, their successes and their failures. To be held Friday, September 28, 2018.
See attachment for additional information and registration.
Notice of Webinar for PAR-18-307 "Developing Interventions for Health-Enhancing Physical Activity
(R21/R33 - Clinical Trial Optional)" and PAR-18-324 "Testing Interventions for Health-Enhancing
Physical Activity (R01 - Clinical Trial Optional)" (NOT-OD-18-220)
Notice of Change in Eligible Organizations in PAR-18-466 The NCI Transition Career Development
Award (K22 Independent Clinical Trial Required)" to Allow Foreign Components in Domestic
Notice of Change in Eligible Organizations in PAR-18-467 The NCI Transition Career Development
Award (K22 Independent Clinical Trial Not Allowed)" to Allow Foreign Components in Domestic
Notice of Correction to Key Dates for PAR-17-206 "Alliance of Glycobiologists for Cancer Research:
Translational Tumor Glycomics Laboratories (U01)" (NOT-CA-18-097)
Notice of Correction to Key Dates for PAR-17-207 "Alliance of Glycobiologists for Cancer Research:
Biological Tumor Glycomics Laboratories (U01)" (NOT-CA-18-098)
Notice of NCI Participation in PAR-18-881, Short-term Mentored Career Enhancement Awards in
Mobile and Wireless Health Technology and Data Analytics: Cross-Training at the intersection of
Behavioral and Social Sciences and STEM Disciplines (NOT-CA-18-099)
Notice of NCI Participation in PAR-18-882, Short-term Mentored Career Enhancement Awards in
Mobile and Wireless Health Technology and Data Analytics: Cross-Training at the Intersection of
Behavioral and Social Sciences and STEM Disciplines (NOT-CA-18-100)
Expert Panel Meeting to Discuss Research Methodologies to Understand Long-term Consequences
of Prenatal Opioid and other Substance Exposure on Brain and Behavioral Development (NOT-DA-18-030)
Notice of Clarification of NOT-ES-18-009, Expiration of RFA-ES-16-004 "Maintain and Enrich
Resource Infrastructure for Existing Environmental Epidemiology Cohorts (R24)" (NOT-ES-18-010)
Notice of Modifications to Application Instructions in PAR-17-341 "National Institute of General
Medical Sciences Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral
Institutional Research Training Grant (T32)" (NOT-GM-18-040)
Notice of NHGRI, NIAID, NLM, and NCI Participation in PAR-18-714-Academic Research Enhancement
Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed) (NOT-HG-18-013)
Notice to Extend the Expiration Date for PAR-16-021 "NHLBI TOPMed: Omics Phenotypes of Heart,
Lung, and Blood Disorders (X01)" (NOT-HL-18-645)
Notice of Correction to Funding Opportunity Description and Application and Submission Information
in RFA-HL-19-005 Management of Asthma in Primary Care - Clinical Center
(UG3/UH3 - Clinical Trial Required) (NOT-HL-18-646)
Notice of NIMHDs Participation in NOT-OD-04-047 "High Priority, Short-Term Project Award (R56)"
Notice of Change of Receipt Date for RFA-MD-18-007 "NIMHD Minority Health and Health
Disparities Research Training (MHRT) Program (T37) (NOT-MD-18-011)
Notice of Pre-Application Webinar for RFA-MD-18-007 NIMHD Minority Health and Health
Disparities Research Training (MHRT) Program (T37) (NOT-MD-18-012)
Administrative Supplements for Validation of Novel Non-Addictive Pain Targets (Clinical Trials
Not Allowed) (NOT-NS-18-073)
Notice of Intent to Publish a Funding Opportunity Announcement for Discovery and Validation of
Novel Targets for Safe and Effective for Pain Treatment (R01 Clinical Trial Not Allowed) (NOT-NS-18-080)
Please Note: When only one application is allowed per Institution according to the sponsor
instructions, a one-page letter of intent summarizing the proposed project should be submitted
to the Vice President for Research at least one month prior to the application deadline (unless
otherwise noted). The letters of intent will be reviewed and a single application will be chosen
for submission from the University.
Improving Smoking Cessation Interventions among People Living with HIV (R01 Clinical Trial Optional)
(RFA-CA-18-027) – Deadline January 8, 2019
Improving Smoking Cessation Interventions among People Living with HIV (R21 Clinical Trial Optional)
(RFA-CA-18-028) – Deadline January 8, 2019
Limited Competition for the Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network
(NASH CRN) Clinical Centers (U01 Clinical Trial Required) (RFA-DK-18-505) – Deadline October 31, 2018
Limited Competition for the Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network
(NASH CRN) Data Coordinating Center (U24 Clinical Trial Required) (RFA-DK-18-506)
Deadline October 31, 2018
Data Integration and Resource Center (DIRC) for Common Fund Acute to Chronic Pain Signatures
Program (U54 Clinical Trial Optional) (RFA-RM-18-031) – Deadline October 24, 2018
Omics Data Generation Centers (ODGCs) for Common Fund Acute to Chronic Pain Signatures
Program (U54 Clinical Trial Optional) (RFA-RM-18-032) – Deadline October 24, 2018
Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Pain from
Musculoskeletal Trauma (UM1 Clinical Trial Optional) (RFA-RM-18-033) – Deadline October 24, 2018
Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Peri-Operative
Pain (UM1 Clinical Trial Optional) (RFA-RM-18-034) – Deadline October 24, 2018
Clinical Coordination Center for Common Fund Acute to Chronic Pain Signatures (A2CPS) Program
(U24 Clinical Trial Optional) (RFA-RM-18-035) – Deadline October 24, 2018
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial
Not Allowed) (PA-18-906) – Deadline varies. Go to
https://grants.nih.gov/grants/guide/contacts/Diversity-Supp_contacts.html for information regarding deadlines.
Society for Immunotherapy of Cancer (SITC) and the Melanoma Research Alliance (MRA) –
Young Investigator Award in Immune-Related Adverse Events (MRA’s 2018-2019 RFP-2nd Release
Deadline November 2, 2018